NEW YORK (Reuters) – Bankrupt Oxycontin manufacturer Purdue Pharma can shield its owners, members of the wealthy Sackler family, from opioid lawsuits in exchange for a $6 billion contribution to the company’s broader bankruptcy settlement, a U.S. appeals court ruled on Tuesday. (Reporting by Dietrich Knauth)
Health
Purdue Pharma can protect Sackler owners in opioid bankruptcy, court rules
NEW YORK (Reuters) – Bankrupt Oxycontin manufacturer Purdue Pharma can shield its owners, members of the wealthy Sackler family, from opioid lawsuits in exchange for a $6 billion contribution to the company’s broader bankruptcy settlement, a U.S. appeals court ruled on Tuesday.
(Reporting by Dietrich Knauth)